We use cookies

Our website uses essential cookies and, with your consent, additional cookies to measure performance and improve our services. Cookie Policy.

You can change your choice at any time.

MMedXYNews
HomeVideos
MedXY AI/MedXY News/Section: Infectious Diseases

A Novel H3N2 Variant on the Rise: What Clinicians and Public Health Systems Need to Know for 2025–26

MedXY Editorial Team•Nov 14, 2025•Infectious Diseases
influenzasurveillance

Highlight

• A rapidly evolving influenza A(H3N2) subclade (referred to as subclade K) has been reported in the southern hemisphere and is rising in the UK, with mutations that differ from the 2025 vaccine strain.

• Early international reports suggest increased case counts concentrated in children and young adults; severity signals and geographic spread to the northern hemisphere remain uncertain.

MedXY registered readers

Sign in free to continue reading

Create or use your MedXY account to unlock the complete article.

This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.

Related articles

Open language-specific specialty feeds and department pages.

Distinct Symptom Profiles and Outcomes of Respiratory Pathogens in Young US Children: Insights From a 2019-2025 Cohort StudyThis longitudinal study characterizes symptom variability and outcomes of respiratory infections among young children, revealing age-specific severity patterns and notable differences between influenza A and B.Aug 17, 2026Decoding the Pulmonary Immune Landscape in Influenza: Insights from a Large-Scale Single-Cell AtlasA comprehensive single-cell atlas of lung immune cells reveals distinct immune responses in mild versus severe influenza, highlighting neutrophil dysfunction and lymphocyte impairment as key drivers of pathology.Jul 17, 2026When to Image: Expert Consensus on Staging and Surveillance Imaging for Cutaneous Squamous Cell CarcinomaA multidisciplinary Delphi panel offers practical, consensus-based recommendations to standardize when and how to use staging and surveillance imaging for localized cutaneous squamous cell carcinoma (CSCC).Jul 12, 2026
Loading comments...
MedXY briefing

Get the free newsletter

Evidence-led clinical news, trends, and analysis—delivered to your inbox.

Ask MedXY AI

Most popular

Intimate Health
Five Benefits for Women Continuing Sexual Activity After Menopause
Intimate Health
Why Some Women Have a Strong Sex Drive—And Why Men Shouldn't Worry About It
Nursing & care
How often should a couple have sex?
Intimate Health
Classic Intimacy Recommendations: How to Help Women Reach Orgasm and Enjoy Mutual Pleasure
Intimate Health
What Makes a Woman "Physiologically Addicted" Is Never Money, But These Two Relationship Qualities
© 2026 MedXY
Contact usAbout usPrivacy PolicyMedXY story
Prompt and Intensive Antiviral Chemoprophylaxis in Nursing Home Influenza Outbreaks: Evidence Synthesis and Clinical Implications
Intensive oseltamivir chemoprophylaxis for ≥70% of nursing home residents within 2 days of influenza outbreak reduces hospitalization risk, underscoring prompt antiviral intervention as a critical outbreak control strategy.
Jun 15, 2026
Early, Broad Oseltamivir Prophylaxis May Cut Hospitalizations in Nursing Home Influenza OutbreaksPrompt oseltamivir prophylaxis covering at least 70% of eligible nursing home residents within 2 days of outbreak detection was associated with fewer hospitalizations, but not lower mortality.Jun 15, 2026
Fast, Broad Oseltamivir Use in Nursing Home Flu Outbreaks May Cut HospitalizationsIn a real-world target trial emulation, starting oseltamivir prophylaxis within 2 days for at least 70% of eligible nursing home residents was linked to fewer hospitalizations, but not lower short-term mortality.Jun 15, 2026